Investigational New Drug
Entity.
- Evidence
- 66 documents · 17 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 12 Apr 2026, last seen 20 Oct 2026
- Measured
- 3% of mentions say something specific about it; the rest only name it
- As of
- 21 Oct 2026
Where this comes from
- FDA · 2026-10-09 · Phase 1 Investigational New Drug (IND) Navigator (opens the source in a new tab)
- FDA · 2026-10-09 · Phase 1 IND Frequently Asked Questions (opens the source in a new tab)
- FDA · 2026-09-17 · Investigational New Drug Application (IND) (opens the source in a new tab)
- FDA · 2026-09-16 · FDA Expedited Investigational New Drug (IND) Pilot Program (opens the source in a new tab)
- FDA Drug News · 2026-09-16 · Expedited Investigational New Drug Pilot Program - Application Instructions (opens the source in a new tab)
- FDA Drug News · 2026-06-24 · IND Application Reporting: IND Safety Reports (opens the source in a new tab)
- FDA Drug News · 2026-06-18 · Investigational New Drug (IND) Application (opens the source in a new tab)
- FDA Drug News · 2026-06-15 · Importing Investigational New Drugs (opens the source in a new tab)
- FDA Drug News · 2026-06-10 · Final Rule: Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequ… (opens the source in a new tab)